Brief: Willow Biosciences Comments On Descheduling Of Partner's Cannabidiol By U.S. Drug Enforcement Agency
03/12/2019 12:44
Dec 3 (Reuters) - Willow Biosciences Inc WLLW.CD :
* WILLOW BIOSCIENCES COMMENTS ON DESCHEDULING OF PARTNER'S
CANNABIDIOL BY U.S. DRUG ENFORCEMENT AGENCY
Source text for Eikon: ID:nCNWKrMCQa
Further company coverage: WLLW.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atlas Energy
See all newsBrief: Atlas Energy Corp. Announces Appointments To Subsidiary Board And Extension Of Tsxv Sandbox Exit Deadline
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Strengthens Leadership Team With Appointment Of Andy Duncan As Senior Executive
Brief: Willow Biosciences Announces Completion Of Transformative Recapitalization Transactions To Form Atlas Energy Corp